Page 41 - Read Online

Page 10 of 14 Afyouni et al. Hepatoma Res 2023;9:28 https://dx.doi.org/10.20517/2394-5079.2023.29

radiology and AI has the potential to revolutionize ICC management, leading to improved patient outcomes
and personalized treatment strategies. However, continued research, collaboration, and careful
consideration of ethical and data security issues are essential to successfully translate AI-based tools into
clinical practice.

DECLARATIONS
Authors’ contributions
Contributed significantly to the creation of this manuscript: Afyouni S, Borhani A, Mohseni A, Mirza-
Aghazadeh-Attari M, Madani SP, Shahbazian H, Zandieh G, Pawlik TM, Kamel IR

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Not applicable.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Jiang Y, Jiang L, Li F, et al. The epidemiological trends of biliary tract cancers in the United States of America. BMC Gastroenterol
2022;22:546. DOI PubMed PMC
2. Sripa B, Brindley PJ, Mulvenna J, et al. The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. Trends
Parasitol 2012;28:395-407. DOI PMC
3. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing
cholangitis. Am J Gastroenterol 2004;99:523-6. DOI PubMed
4. Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical
presentation. Scand J Gastroenterol 2002;37:1205-11. DOI
5. Cheng R, Du Q, Ye J, Wang B, Chen Y. Prognostic value of site-specific metastases for patients with advanced intrahepatic
cholangiocarcinoma: a SEER database analysis. Medicine 2019;98:e18191. DOI PubMed PMC
6. Chan KM, Tsai CY, Yeh CN, et al. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic
factor, and recurrence. BMC Gastroenterol 2018;18:180. DOI PubMed PMC
7. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol
2014;60:1268-89. DOI
8. Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with
special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 2011;260:148-57. DOI
PubMed
9. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of
histopathologic and MR imaging features. Radiographics 2008;28:747-69. DOI
10. Granata V, Grassi R, Fusco R, et al. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should
assess MR features. Radiol Med 2021;126:1584-600. DOI
11. Granata V, Fusco R, Venanzio Setola S, et al. Major and ancillary features according to LI-RADS in the assessment of combined
hepatocellular-cholangiocarcinoma. Radiol Oncol 2020;54:149-58. DOI PubMed PMC